Rajeev Dadoo
Person ● Covered in 0 stories + Follow ✴ AI Graph Request update
Rajeev Dadoo is a director at Nimbus Therapeutics. He joined SR One in 2004, and his investments there have included Adheron, iPierian, True North, Propeller Health, Concert Pharmaceuticals, CyDex Pharmaceuticals, NeuroTherapeutics Pharma, Tranquis Therapeutics, IlluminOss Medical, and Avhana Health. Earlier in his career, he worked on strategic and operational projects in GSK’s competitive excellence group, held technology and clinical development roles at Genentech, worked in product development at Bio-Rad Laboratories, worked in business development at Genome Therapeutics, and co-founded Unimicro Technologies. He is known for his investing work and for experience spanning biotech product development, clinical development, business development, and strategy.
Updated 10 September 2026
Public sources: nimbustx.com
Why this page exists, and how to correct or remove it
This profile is assembled automatically because Rajeev Dadoo appears in coverage we index or holds a role listed publicly by their organisation. It uses only public sources — company and organisation pages, news articles, Wikipedia, and public professional listings — and the biography, if any, is written by AI from those sources and cited above.
We hold it to report on the AI industry, under the legitimate interest of journalistic reporting. You can ask us to correct it, restrict it, or take it down, and you can object at any time — no account needed, no reason required.
Claim or correct this profile Request removal How we handle personal data